US3682896A - Preparation of 6-acylaminopenicillanic acids - Google Patents
Preparation of 6-acylaminopenicillanic acids Download PDFInfo
- Publication number
- US3682896A US3682896A US10286A US3682896DA US3682896A US 3682896 A US3682896 A US 3682896A US 10286 A US10286 A US 10286A US 3682896D A US3682896D A US 3682896DA US 3682896 A US3682896 A US 3682896A
- Authority
- US
- United States
- Prior art keywords
- mol
- acetone
- treated
- sodium
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002253 acid Substances 0.000 title abstract description 20
- 150000007513 acids Chemical class 0.000 title abstract description 5
- 238000002360 preparation method Methods 0.000 title description 8
- 229930182555 Penicillin Natural products 0.000 abstract description 12
- 238000000034 method Methods 0.000 abstract description 12
- 239000012038 nucleophile Substances 0.000 abstract description 11
- NGHVIOIJCVXTGV-UHFFFAOYSA-N 6beta-amino-penicillanic acid Natural products OC(=O)C1C(C)(C)SC2C(N)C(=O)N21 NGHVIOIJCVXTGV-UHFFFAOYSA-N 0.000 abstract description 8
- NGHVIOIJCVXTGV-ALEPSDHESA-N 6-aminopenicillanic acid Chemical compound [O-]C(=O)[C@H]1C(C)(C)S[C@@H]2[C@H]([NH3+])C(=O)N21 NGHVIOIJCVXTGV-ALEPSDHESA-N 0.000 abstract description 7
- 150000002960 penicillins Chemical class 0.000 abstract description 7
- 238000003776 cleavage reaction Methods 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 5
- 230000003197 catalytic effect Effects 0.000 abstract description 4
- 238000006243 chemical reaction Methods 0.000 abstract description 4
- 230000007017 scission Effects 0.000 abstract description 4
- 102000004190 Enzymes Human genes 0.000 abstract description 3
- 108090000790 Enzymes Proteins 0.000 abstract description 3
- 230000002163 immunogen Effects 0.000 abstract description 3
- 229920002521 macromolecule Polymers 0.000 abstract description 3
- 239000007858 starting material Substances 0.000 abstract description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 83
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 62
- -1 triethylamine Chemical class 0.000 description 31
- 239000000243 solution Substances 0.000 description 28
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 21
- 239000007787 solid Substances 0.000 description 20
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 18
- 150000002466 imines Chemical class 0.000 description 17
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 17
- 239000000203 mixture Substances 0.000 description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 14
- 238000002329 infrared spectrum Methods 0.000 description 14
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical class N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000012265 solid product Substances 0.000 description 10
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 8
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- FCPVYOBCFFNJFS-LQDWTQKMSA-M benzylpenicillin sodium Chemical compound [Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 FCPVYOBCFFNJFS-LQDWTQKMSA-M 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 229940093499 ethyl acetate Drugs 0.000 description 6
- 235000019439 ethyl acetate Nutrition 0.000 description 6
- 229940049954 penicillin Drugs 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 235000009518 sodium iodide Nutrition 0.000 description 6
- 125000002252 acyl group Chemical group 0.000 description 5
- IYNDLOXRXUOGIU-LQDWTQKMSA-M benzylpenicillin potassium Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 IYNDLOXRXUOGIU-LQDWTQKMSA-M 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 235000019371 penicillin G benzathine Nutrition 0.000 description 5
- 229940056360 penicillin g Drugs 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- RZWQDAUIUBVCDD-UHFFFAOYSA-M sodium;benzenethiolate Chemical group [Na+].[S-]C1=CC=CC=C1 RZWQDAUIUBVCDD-UHFFFAOYSA-M 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 3
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 3
- 230000003301 hydrolyzing effect Effects 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 229940116357 potassium thiocyanate Drugs 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 2
- RBKMMJSQKNKNEV-RITPCOANSA-N penicillanic acid Chemical compound OC(=O)[C@H]1C(C)(C)S[C@@H]2CC(=O)N21 RBKMMJSQKNKNEV-RITPCOANSA-N 0.000 description 2
- ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000003573 thiols Chemical class 0.000 description 2
- FZENGILVLUJGJX-NSCUHMNNSA-N (E)-acetaldehyde oxime Chemical compound C\C=N\O FZENGILVLUJGJX-NSCUHMNNSA-N 0.000 description 1
- OFYLBLSSPQTTHT-VMPITWQZSA-N (NE)-N-(pyridin-4-ylmethylidene)hydroxylamine Chemical compound O\N=C\C1=CC=NC=C1 OFYLBLSSPQTTHT-VMPITWQZSA-N 0.000 description 1
- KGGVGTQEGGOZRN-PLNGDYQASA-N (nz)-n-butylidenehydroxylamine Chemical compound CCC\C=N/O KGGVGTQEGGOZRN-PLNGDYQASA-N 0.000 description 1
- ZAUCRONGJXRQRD-UHFFFAOYSA-N 2,6-dimethoxybenzamide Chemical compound COC1=CC=CC(OC)=C1C(N)=O ZAUCRONGJXRQRD-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
- BPDBLWKFVXHGFT-UHFFFAOYSA-N 3-(2-chlorophenyl)-5-methyl-1,2-oxazole-4-carbonyl chloride Chemical compound ClC(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl BPDBLWKFVXHGFT-UHFFFAOYSA-N 0.000 description 1
- AGQOIYCTCOEHGR-UHFFFAOYSA-N 5-methyl-1,2-oxazole Chemical compound CC1=CC=NO1 AGQOIYCTCOEHGR-UHFFFAOYSA-N 0.000 description 1
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,N‐diethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 125000000649 benzylidene group Chemical group [H]C(=[*])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000000219 ethylidene group Chemical group [H]C(=[*])C([H])([H])[H] 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- 229940006461 iodide ion Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000002911 monocyclic heterocycle group Chemical group 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 229960004894 pheneticillin Drugs 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-M toluene-4-sulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-M 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Definitions
- 6-aminopenicillanic acid and 6-acylaminopenicillanic acids are prepared free from immunogenic macromolecules, for use in producing semi-synthetic penicillins, by a reaction under anhydrous conditions avoiding the use of enzymes and without hydrolytic cleavage of the 5- lactam ring structure.
- the preferred process includes the use of a nucleophile in at least a catalytic amount for treating the starting material.
- a substance may also be employed which is both a nucleophile and an acid acceptor.
- This invention relates to the preparation of penicillanic acids and is particularly concerned with the preparation of 6-aminopenicillanic acid and penicillins from N-(6- aminopenicillanoyloxy) imines or N-(6-substituted penicillanoyloxy) irnines.
- An advantage of the present invention is that the reaction takes place under anhydrous conditions and thus there is no danger of hydrolytic cleavage of the sensitive S-lactam ring of the compounds involved.
- 0N-- HCO-ON CHR (II) or its acid addition salt wherein R is an alkyl, aryl or heterocyclic group in an organic solvent or mixture of organic solvents with an acid acceptor.
- the acid acceptor may be a source of alkali metal ions or a tertiary amine, e.g. triethylamine, and it is preferably employed in at least one molecular proportion.
- the group R in Formula II may be an alkyl group, especially an alkyl group having from 1 to 6 carbon atoms such as, methyl, ethyl, propyl or butyl; an aryl group such as phenyl; a heterocyclic group, particularly a monocyclic heterocyclic group such as pyridyl or furfuryl.
- the compound (II) is treated with a nucleophile in addition to the acid acceptor, said nucleophile being present in at 3,682,896 Patented Aug. 8, 1972 least a catalytic amount.
- nucleophile may be used, particularly suitable ones being thiols, the thiocyanate ion and the iodide ion.
- a single substance may be employed which functions as both acid acceptor and nuleophile.
- An example of one such substance is sodium thiophenoxide, which provides sodium ions as the acid acceptor and Ph& ions as the nucleophile.
- X in the above general formulae is an acyl group it is particularly convenient to select the solvents and reagents in such a way that a salt of the resulting penicillanic acid (I) crystallizes from the mixture, either directly or after the addition of another suitable solvent. It is in fact one function of the acid acceptor to provide the cation of such a salt.
- the reagents are triethylamine and a catalytic amount of thiophenol then, provided the solvent has been suitably chosen, the triethylamine salt of the penicillin crystallizes.
- the nature of the solid product will depend on the solubilities of the two penicillin salts in the particular solvent ssytem.
- a bermylpenicillin derivative in acetone is treated with one molecular proportion each of triethylamine and potassium thiocyanate it is found in practice that the crystalline product is the potassium rather than the triethylamine salt of benzylpenicillin.
- the desired cleavage reaction takes place but no product crystallizes, in which case other procedures must be adopted to recover the product.
- One such procedure is to remove all or part of the organic solvent in vacuo, dilute the residue with water, and adjust to a suitable pH.
- this pH may be low (about 2) and the free acid form of the penicillin may be extracted into a suitable organic solvent, and recovered therefrom by conventional means.
- X is hydrogen
- a suitable pH is in the neighborhood of the isoelectric point of 6APA (i.e. about 4.3), so that this product may crystallize directly from the aqueous solution.
- the solution was treated with 1.67 N sodium 2-ethylhexoate in methyl isobutyl ketone (0.6 m1., 0.001 mol.) followed by 2-ethyl hexoic acid (0.16 ml., 0.001 mol.) and evaporated under reduced temperature and pressure.
- the residual yellow oil was dissolved in methyl isobutyl ketone saturated with water (40 ml.), diluted with dry methyl isobutyl ketone (60 ml.) and stirred at room temperature for 1 /2 hours.
- the crystalline solid produced was filtered off, washed with methyl isobutyl ketone and dried in vacuo to give the penicillin monohydrate 0.3 g. (63.1%) as a colorless crystalline solid identical with authenic material by infrared spectra.
- EXAMPLE 4 Sodium u-phenoxyethyl penicillin N-[6 (on phenoxypropionamido)penicillanoyloxy]- Z-furfurylidene imine (0.46 g., 0.001 mol.), dissolved in a mixture of dimethyl formamide (1 ml.) and thiophenol (1 drop), was treated with triethylamine (0.14 ml.) and stood at room temperature for 2 hours. The reaction solution was treated with 1.67 N sodium 2- ethylhexoate in methyl isobutyl Igetone. ,0.6 ml.) and evaporated under reduced temperature and pressure.
- N [6 (phenylacetamido)penicillanoyloxy]ben zylidene imine (2.14 g., 0.005 mol.) was added to a solution of sodium thiocyanate (0.41 g., 0.005 mol.) in dry acetone (5 ml.) and treated with triethylamine (0.7 ml.). The mixture was stirred at room temperature for 2% hours. The solid product was filtered off, washed well with acetone and dried in vacuo to give a colorless crystalline solid 1.15 g. (64.6%) shown to be identical with authentic sodium benzylpenicillin by infra-red spectra.
- EXAMPLE 7 Benzylpenicillin potassium salt N [6 (phenylacetamido)penicillanoyloxy]benzylidene imine (2.14 g., 0.005 mol.) was added to a solution of potassium thiocyanate (0.49 g., 0.005 mol.) in dry acetone (10 ml.) and treated with triethylamine (0.7 ml.). The mixture was stirred at room temperature for 4 hours. The solid product was filtered oflf, washed well with acetone to give a colorless crystalline solid 1.38 g. (74.2%) shown to be identical with authentic potassium benzylpenicillin by infra-red spectra.
- EXAMPLE 9 Sodium 2.6-dimethoxyphenylpenicillin (a) N- 6-(2,6-dimethoxybenzamido)penicillanoyloxy]- 2-furfurylidene imine (0.47 g., 0.001 mol.) in a mixture of dimethylformamide (1 ml.) and thiophenol (1 drop) was treated with triethylamine (0.14 ml.) and stood at room temperature for 2 hours. The yellow solution was treated with 1.67 N sodium 2-ethylhexoate in methyl isobutyl ketone (0.6 m1.) and evaporated under reduced temperature and pressure.
- EXAMPLE 11 Sodium benzylpenicillin N ['6 (phenylacetamido)pencillanoyloxy]pyridine-4- ylidene imine (2.19 g., 0.005 mol.) in dry acetone (20 ml.) was treated with a solution of sodium iodide (0.75 g., 0.005 mol.) in dry acetone (10 ml. followed bytriethylamine (0.7 ml.) as described in Example 6(a) to give a colorless crystalline solid 0.56 g. (31.5%) shown to be identical with authentic material by infra-red spectra.
- EXAMPLE 13 Sodium benzylpenicillin N-[6 (phenylacetamido)pencillanoyloxy]butyrylidene imine (0.8 g., 0.002 mol.) in dry acetone (10 ml.) was treated with a solution of sodium iodide (0.3 g.) in dry acetone (5 ml.) followed by triethylamine (0.28 ml.) as described in Example 6(a) to give a colorless crystalline solid 0.16 g. (22.5%) shown to be identical with authentic material by infra-red spectra.
- EXAMPLE 14 6-aminopenicillanic acid N-(6-aminopenicillanoyloxy)benzylidene imine p-toluene sulphonate (0.49 g., 0.001 mol.) in diethylformamide (1 ml.) was treated with triethylamine (0.28 ml.) and thiophenol (2 drops) and stood at room temperature for 4 hours. The solution was diluted with water (5 ml.) and washed with ether (2X 5 ml.). The clear aqueous layer was adjusted to pH 4 with N hydrochloric acid and stirred for 16 hours. The solid product was filtered off, washed with water, dried in vacuo to give a cream colored crystalline solid 0.09 g. (41.7%) shown to be identical with authentic 6-aminopenicillanic acid by infra-red spectra.
- EXAMPLE 16 Sodium benzylpenicillin N [6 (phenylacetamido)penicillanoyloxy]ethylidene imine (1.28 g.) in dry acetone (20 ml.) was treated with a solution of sodium iodide (0.52 g.) in dry acetone (5 m1.) followed by triethylamine (0.5 ml.) and stirred at room temperature for 2 hours. The solid was filtered off, washed well with acetone and dried in vacuo to give a colorless crystalline solid 0.42 g. (34.6%) shown to be identical with authentic material.
- R is lower alkyl of 1 to 6 carbon atoms, phenyl pyridyl or furfuryLin an organic solvent selected from acetone, dimethylformamide, thiophenol, ethanethiol and mixtures thereof, with sodium or potassium iodide or thiocyanate or sodium thiophenoxide, or triethylamine as acid acceptor.
- a process according to claim 1 in which the acid acceptor is present in at least one molecular proportion. 3. A process according to claim 1, in which is further present a thiol, thiocyanate or iodide as nucleophile.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7756/69A GB1255035A (en) | 1969-02-13 | 1969-02-13 | Preparation of penicillanic acids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3682896A true US3682896A (en) | 1972-08-08 |
Family
ID=9839124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US10286A Expired - Lifetime US3682896A (en) | 1969-02-13 | 1970-02-10 | Preparation of 6-acylaminopenicillanic acids |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US3682896A (de) |
| AT (1) | AT293619B (de) |
| BE (1) | BE745901A (de) |
| BR (1) | BR7016628D0 (de) |
| CH (1) | CH544772A (de) |
| DE (1) | DE2006199A1 (de) |
| ES (1) | ES376436A1 (de) |
| FR (1) | FR2034544A1 (de) |
| GB (1) | GB1255035A (de) |
| IE (1) | IE33955B1 (de) |
| NL (1) | NL7001685A (de) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3948927A (en) * | 1972-04-10 | 1976-04-06 | Queen's University | 2,2-Dimethyl-3R-carboxy-6S-amino-1-oxa-4-aza-5R-bicyclo-[3,2,0]heptan-7-one |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670103U (de) | 1952-05-21 | 1954-01-14 | Hagenuk Hanseatische Appbau Ge | Anzeigeeinrichtung mit zwei achsengleichen zeigern. |
| DE1937962U (de) | 1965-02-19 | 1966-05-05 | Porsche Kg | Anordnung zur axialsicherung des abtriebskegelrades eines ausgleichsgetriebes. |
-
1969
- 1969-02-13 GB GB7756/69A patent/GB1255035A/en not_active Expired
-
1970
- 1970-01-23 IE IE91/70A patent/IE33955B1/xx unknown
- 1970-02-05 NL NL7001685A patent/NL7001685A/xx unknown
- 1970-02-06 BR BR216628/70A patent/BR7016628D0/pt unknown
- 1970-02-10 ES ES376436A patent/ES376436A1/es not_active Expired
- 1970-02-10 US US10286A patent/US3682896A/en not_active Expired - Lifetime
- 1970-02-11 FR FR7004753A patent/FR2034544A1/fr not_active Withdrawn
- 1970-02-11 AT AT121870A patent/AT293619B/de not_active IP Right Cessation
- 1970-02-11 DE DE19702006199 patent/DE2006199A1/de active Pending
- 1970-02-11 CH CH193270A patent/CH544772A/de not_active IP Right Cessation
- 1970-02-12 BE BE745901D patent/BE745901A/xx unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3948927A (en) * | 1972-04-10 | 1976-04-06 | Queen's University | 2,2-Dimethyl-3R-carboxy-6S-amino-1-oxa-4-aza-5R-bicyclo-[3,2,0]heptan-7-one |
Also Published As
| Publication number | Publication date |
|---|---|
| BE745901A (fr) | 1970-08-12 |
| CH544772A (de) | 1973-11-30 |
| GB1255035A (en) | 1971-11-24 |
| AT293619B (de) | 1971-10-25 |
| DE2006199A1 (de) | 1970-09-03 |
| ES376436A1 (es) | 1972-04-16 |
| BR7016628D0 (pt) | 1973-06-07 |
| NL7001685A (de) | 1970-08-17 |
| FR2034544A1 (de) | 1970-12-11 |
| IE33955B1 (en) | 1974-12-30 |
| IE33955L (en) | 1970-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3325479A (en) | Derivatives of aminoacylpenicillins and a process for their preparation | |
| US3652546A (en) | Esters of 6-aminopenicillanic acid | |
| US3632578A (en) | Cleavage of acylamidocephalosporins and acylamidopenicillins | |
| US3311638A (en) | Anhydropenicillins | |
| US3682896A (en) | Preparation of 6-acylaminopenicillanic acids | |
| DK143342B (da) | Cephalosporin-forbindelser til anvendelse som mellemprodukter ved fremstilling af cphalexon og fremgangsmaade til fremstilling af disse forbindelser | |
| US3663563A (en) | Esters of 6-aminopenicillanic acid | |
| US3647787A (en) | Process improvement for converting penicillin sulfoxide esters to cephem compounds | |
| US3284451A (en) | Activated esters of 7-amino-cephalosporanic acid | |
| US3316273A (en) | Penicillin aldehydes | |
| US4210750A (en) | Process for the preparation of 3-carbamoyl cephalosporins using isocyanates | |
| US3720664A (en) | Alpha-ureidocyclohexadienylalkylene-penicillins | |
| KR830001969B1 (ko) | 6―{D―(―) α-(4―에틸-2. 3-디옥소-1 피페라지노카보닐아미노) 페닐(또는 하이드록시페닐)아세트아미도 페니실란산 및 그 염의 제조방법 | |
| US4237280A (en) | Intermediate for cephalosporin type compound | |
| DK156221B (da) | Fremgangsmaade til fremstilling af penicillansyre- og cephalosporansyrederivater | |
| US3449336A (en) | Process for preparing novel intermediates useful for preparing 7-amino-cephalosporanic acid and derivatives thereof | |
| US3296250A (en) | 4-thiazolylmethylpenicillins | |
| SU576046A3 (ru) | Способ получени производных пенициллина или их солей | |
| US3720665A (en) | Acyloxymethyl esters of alpha-preidocyclo-hexadienylalkylene-penicillins | |
| US4446069A (en) | Process for the preparation of β-lactam antibiotics | |
| US3301811A (en) | Nu-hydroxypenicillin amides | |
| US4889929A (en) | Preparation of 1'-ethoxycarbonyl-oxyethyl esters of penicillins | |
| US3876630A (en) | Process for producing penicillin esters | |
| US4289894A (en) | Pentachlorophenyl-phenyl malonate compound suitable for use as acylating agents | |
| KR800000791B1 (ko) | 세펨유도체의 제조법 |